Originally Published MX March/April 2006

COVER STORY

As physicians continue to employ radio-frequency ablation (RFA) for the thermal ablation of nonresectable liver tumors, a growing published body of evidence-based medicine is supporting the clinical adoption of RFA for other applications.

At the annual meeting of the Radiological Society of North America (Oak Brook, IL) in November 2005, several papers were presented that demonstrate the safety and efficacy of RFA for treating patients with renal, lung, and other tumors. According to RITA Medical (Fremont, CA), these papers also reflect the determination among physicians to expand the use of RFA in the treatment of cancer.